Literature DB >> 29405628

Death-specific rate due to asthma and chronic obstructive pulmonary disease in Iran.

Mehdi Varmaghani1,2, Abbas Kebriaeezadeh3, Farshad Sharifi2,4, Ali Sheidaei2,5, Arash Rashidian6, Maziar Moradi-Lakeh7, Roozbeh Naghshin8, Mostafa Moin9, Parinaz Mehdipour2, Elham Heidari2, Kimiya Gohari2,10, Nazila Rezaei2, Rosa Haghshenas2, Farzad Kompani11, Farshad Farzadfar2,12.   

Abstract

BACKGROUND AND
OBJECTIVE: Asthma and chronic obstructive pulmonary disease (COPD) could be considered as a major health problem in industrialized and developing countries. This study was designed to analyze the trends of mortality from asthma and COPD at national and subnational levels in Iran based on National Death Registry, from 2001 to 2015.
MATERIALS AND METHODS: We used Death Registration System (DRS) as the basic source of data. Death Registration System data were available from 1995 to 2010 in Iran's Ministry of Health. Although, Tehran and Isfahan, 2 most populated cities in Iran, had independent death registry systems in their cemeteries, by combining their data we achieved more comprehensive and representative data on death among Iranian people. We addressed incompleteness and misclassification of death registry system using demographic and statistical methods. We also employed spatio-temporal and Gaussian process regression to extrapolate and interpolate mortality rates for the missing data.
RESULTS: Age-standardized asthma mortality rate was 7.2 (5.6-9.2) in females and 8.8 (6.9-11.1) in males at the national level in 2015. Age-standardized COPD mortality rates in females and males, respectively, were 8.46 (6.6-10.9) and 12.38 (9.8-15.6) during the studied years. A reduction in age-standardized asthma mortality was observed during the period of study. In addition, the trend of COPD mortality was increasing.
CONCLUSIONS: It seems that mortality rate attributable to COPD has risen during the past 15 years in Iran. It could have increased because of increased exposure of people to related risk factors such as air pollution which is a common problem in larger cities and border provinces.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  COPD; Iran; asthma; mortality

Mesh:

Year:  2018        PMID: 29405628     DOI: 10.1111/crj.12776

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  5 in total

1.  The Economic Burden of Smoking-Attribution and Years of Life Lost due to Chronic Diseases in Mashhad, 2015-2016.

Authors:  Mehdi Varmaghani; Malihe Ghobadi; Farshad Sharifi; Payam Roshanfekr; Ali Sheidaei; Masoume Mansouri; Amin Adel; Mohammad Mohammadi; Mohammad Reza Masjedi
Journal:  Int J Prev Med       Date:  2021-02-24

2.  Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study.

Authors:  Fatemeh Khosravi Shadmani; Farshad Farzadfar; Bagher Larijani; Moghadameh Mirzaei; Ali Akbar Haghdoost
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

3.  Prevalence of Ever Self-Reported Asthma and Associated Factors among University Students in Iran: A Population-Based Study.

Authors:  Masoume Mansouri; Farshad Sharifi; Seyed Saeed Tabatabaee; Elham Heidari; Hamid Yaghubi; Abasali Keshtkar; Yousef Moghadas Tabrizi; Masoud Arzaghi; Mehdi Varmaghani
Journal:  Int J Prev Med       Date:  2020-04-30

4.  Efficiency of Nebulizing Furosemide in the Treatment of Chronic Pulmonary Obstructive Disease: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Abas Ghaysouri; Gholam Basati; Morteza Shams; Hamed Tavan
Journal:  Tanaffos       Date:  2020-12

5.  The burden of cardiovascular and respiratory diseases attributed to ambient sulfur dioxide over 26 years.

Authors:  Katayoun Rabiei; Nizal Sarrafzadegan; Ali Ghanbari; Mansour Shamsipour; Mohammad Sadegh Hassanvand; Heresh Amini; Masud Yunesian; Farshad Farzadfar
Journal:  J Environ Health Sci Eng       Date:  2020-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.